# A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

> **NCT00093899** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 611 (actual)

## Conditions studied

- Hyperlipidemia
- Hypercholesterolemia
- Hypertriglyceridemia

## Interventions

- **DRUG:** ezetimibe (+) simvastatin

## Key facts

- **NCT ID:** NCT00093899
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 611 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093899, "A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00093899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*